Meet Fernando, a prostate cancer patient
At the age of 55, in apparent perfect health [...]
Meet Tom, a neuroendocrine tumor patient
Tom Bajoras is a composer, pianist, audio producer and [...]
The Oncidium foundation goes live !
After six months of hard labor, research and discussions, welcome [...]
SNMICON 2019
Event: Oncidium Talk during SNMICOM Date: 14 December 2019 Time: [...]
International Symposium Bad Berka 2019
Event: The Inauguration of the ICPO Foundation & The 20th [...]
Ra-224-Radium Chloride (224-SpondylAT®)
224Ra-Radium Chloride was used for a long time between the [...]
I-131-Tositumomab (Bexxar®)
131I-Tositumomab is a radiolabeled anti-CD20 antibody launched in 2003 under [...]
Y-90-OPS201 (SOMTher®)
90Y-OPS201 (90Y-DOTA-JR11, 90Y-SOMTher®) is a proprietary drug that specifically binds [...]
Y-90-DOTATOC (Edotreotide)
90Y-Edotreotide (90Y-DOTATOC, 90Y-Onalta®) is a drug which is actually developed [...]
Y-90-DOTALAN (Lanreotide)
90Y-DOTALAN (90Y-Lanreotide, 90Y-Somatulin) is a generic drug that specifically binds [...]
